- Home
- ZGM vs CASI Comparison
ZGM vs CASI Comparison
Compare ZGM & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZGM | CASI |
|---|---|---|
| Founded | 2019 | 1991 |
| Country | Macau | China |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.0M | 24.9M |
| IPO Year | 2025 | 1996 |
Fundamental Metrics
Financial Performance| Metric | ZGM | CASI |
|---|---|---|
| Price | $2.08 | $0.85 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 25.0K | ★ 35.7K |
| Earning Date | 02-08-2026 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 401.52 | N/A |
| EPS | ★ 0.17 | N/A |
| Revenue | $3,620,780.00 | ★ $26,846,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $12.01 | ★ N/A |
| Revenue Growth | ★ 211.78 | 21.72 |
| 52 Week Low | $1.90 | $0.75 |
| 52 Week High | $4.51 | $3.29 |
Technical Indicators
Market Signals| Indicator | ZGM | CASI |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 41.28 |
| Support Level | N/A | $0.83 |
| Resistance Level | N/A | $0.95 |
| Average True Range (ATR) | 0.00 | 0.08 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 0.00 | 45.73 |
Price Performance
Historical ComparisonAbout ZGM Zenta Group Company Limited Ordinary Shares
Zenta Group Co Ltd is engaged in the provision of industrial park consultation services, business investment consultation services to clients through LIC, and sales of fintech products and services through LFT. Its industrial park consultation services are focused on the pre-development stage. Its business investment consultation services, offered through LIC, mainly focus on assisting clients to acquire stakes in specific investments, and it's normally in the form of equity ownership.
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.